Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?

Dirk Rades

doi:10.1016/j.oraloncology.2008.03.015

Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?

Dirk Rades^*

^*Korrespondierende/r Autor/-in für diese Arbeit

Klinik für Strahlentherapie

4 Zitate (Scopus)

Originalsprache	Englisch
Zeitschrift	Oral Oncology
Jahrgang	45
Ausgabenummer	2
Seiten (von - bis)	91-93
Seitenumfang	3
ISSN	1368-8375
DOIs	https://doi.org/10.1016/j.oraloncology.2008.03.015
Publikationsstatus	Veröffentlicht - 02.2009

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dokumente

10.1016/j.oraloncology.2008.03.015

Weitere Links

Link to publication in Scopus

Zitieren

@article{b14e3a3a097d4968a08441fe708f0bd8,

title = "Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: Is it still a reasonable option or too dangerous?",

author = "Dirk Rades",

year = "2009",

month = feb,

doi = "10.1016/j.oraloncology.2008.03.015",

language = "English",

volume = "45",

pages = "91--93",

journal = "Oral Oncology",